121 related articles for article (PubMed ID: 15010358)
1. Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
Vaziri ND; Kim CH; Dang B; Zhan CD; Liang K
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F90-4. PubMed ID: 15010358
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Vaziri ND; Kim CH; Phan D; Kim S; Liang K
Kidney Int; 2004 Jul; 66(1):262-7. PubMed ID: 15200432
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure.
Liang K; Vaziri ND
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E676-81. PubMed ID: 12217884
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.
Szolkiewicz M; Nieweglowski T; Korczynska J; Sucajtys E; Stelmanska E; Goyke E; Swierczynski J; Rutkowski B
Metabolism; 2002 Dec; 51(12):1605-10. PubMed ID: 12489075
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
Vaziri ND; Liang K; Parks JS
Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
[TBL] [Abstract][Full Text] [Related]
6. Hepatic VLDL-TG production and MTP gene expression are decreased in ovariectomized rats: effects of exercise training.
Barsalani R; Chapados NA; Lavoie JM
Horm Metab Res; 2010 Nov; 42(12):860-7. PubMed ID: 20938890
[TBL] [Abstract][Full Text] [Related]
7. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
Mori Y; Hirano T; Nagashima M; Shiraishi Y; Fukui T; Adachi M
Metabolism; 2007 Dec; 56(12):1714-8. PubMed ID: 17998026
[TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure.
Kim C; Vaziri ND
Kidney Int; 2005 Mar; 67(3):1028-32. PubMed ID: 15698441
[TBL] [Abstract][Full Text] [Related]
10. [Pathomechanism of hyperlipoproteinemia in chronic renal failure].
Rutkowski B; Łososowska R; Król E; Kisielnicka E; Zdrojewski Z; Szołkiewicz M; Niewegłowski T; Chmielewski M; Sucajtys E; Swierczyński J; Korczyńska J; Stelmańska E; Goyke E; Bogusławski W
Pol Merkur Lekarski; 2003 Oct; 15(88):322-3; discussion 323-5. PubMed ID: 14974358
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
Vaziri ND
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F262-72. PubMed ID: 16403839
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of VLDL receptor expression in chronic experimental renal failure.
Vaziri ND; Liang K
Kidney Int; 1997 Mar; 51(3):913-9. PubMed ID: 9067930
[TBL] [Abstract][Full Text] [Related]
13. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.
Smith SJ; Cases S; Jensen DR; Chen HC; Sande E; Tow B; Sanan DA; Raber J; Eckel RH; Farese RV
Nat Genet; 2000 May; 25(1):87-90. PubMed ID: 10802663
[TBL] [Abstract][Full Text] [Related]
14. Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl.
Bagdade JD; Yee E; Wilson DE; Shafrir
J Lab Clin Med; 1978 Jan; 91(1):176-86. PubMed ID: 22574
[TBL] [Abstract][Full Text] [Related]
15. In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Collins CA; Voorbach MJ; Zhao G; Mittelstadt SW; Cox BF
Eur J Pharmacol; 2010 Jul; 637(1-3):155-61. PubMed ID: 20385122
[TBL] [Abstract][Full Text] [Related]
16. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
Liang K; Oveisi F; Vaziri ND
Kidney Int; 1998 Mar; 53(3):626-30. PubMed ID: 9507207
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.
Kim S; Kim CH; Vaziri ND
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E813-7. PubMed ID: 15585592
[TBL] [Abstract][Full Text] [Related]
18. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
19. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters.
Casaschi A; Maiyoh GK; Adeli K; Theriault AG
Metabolism; 2005 Mar; 54(3):403-9. PubMed ID: 15736121
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
